We investigated the expression of an apoptosis-associated antigen (Fas) (CD951 on hematopoietic progenitor cells in the presence or absence of interferon-y (IFN-7) andlor tumor necrosis factor-a (TNF-a). CD34' cells freshly isolated from bone marrow did not express Fas. However, IFN-7 andlor TNF-a induced the expression of both the mRNA of Far and Fas itself in a dose-dependent fashion on the surface of CD34+ cells after 48 hours of serum-free cutture. IFN-7 and TNF-a had a synergistic effect on the induction of Fas, when both cytokines were added to the culture. The TNF-a-induced Fas expression is mediated by p55 TNF-a receptor. CD34+ cells cultured in medium alone or with stem cell factor (SCF) showed some slight expression of Fas. When anti-Fas OMEOSTASIS IN MAMMALS is controlled not only by cell proliferation and differentiation, but also by cell death. Apoptosis is a morphologically defined death process, which plays an important role in physiologic cell death. Apoptosis was first described as a biologic phenomenon based on morphologic observations such as cytoplasmic condensation, loss of plasma membrane microvilli, and nuclear condensation coupled with cleavage of DNA to oligonucleosoma1 fragments."' A monoclonal antibody (MoAb) (IgM) raised against an apoptosis-associated antigen (Ag), Fas (CD95), has been found to induce apoptosis of cells by binding to F~s .~ Fas, which is identical to Apo-l Ag:,6 belongs to nerve growth factor receptor (NGFR)/TNF receptor (TNFR) s~perfamily.~.~ Mutations of the Fas gene have been observed in a lymphoproliferation (lpr) mouse model, which develops lymphadenopathy and suffers from a systemic lupus erythematosus-like disease caused by the defect in apoptosis during T-cell de~elopment,~ indicating that Fas plays a role in lymphoid cell development. Lymphoid and hematopoietic cells share common pluripotent stem cells: and Fas is expressed on myeloid cell lines such as HL-60 and U-9374 and terminally differentiated myeloid cells, ie, neutrophils and monocytes.' These facts suggest that Fas may be actively involved in hematopoietic as well as lymphoid cell development.
OMEOSTASIS IN MAMMALS is controlled not only by cell proliferation and differentiation, but also by cell death. Apoptosis is a morphologically defined death process, which plays an important role in physiologic cell death. Apoptosis was first described as a biologic phenomenon based on morphologic observations such as cytoplasmic condensation, loss of plasma membrane microvilli, and nuclear condensation coupled with cleavage of DNA to oligonucleosoma1 fragments."' A monoclonal antibody (MoAb) (IgM) raised against an apoptosis-associated antigen (Ag), Fas (CD95), has been found to induce apoptosis of cells by binding to F~s .~ Fas, which is identical to Apo-l Ag:,6 belongs to nerve growth factor receptor (NGFR)/TNF receptor (TNFR) s~perfamily.~.~ Mutations of the Fas gene have been observed in a lymphoproliferation (lpr) mouse model, which develops lymphadenopathy and suffers from a systemic lupus erythematosus-like disease caused by the defect in apoptosis during T-cell de~elopment,~ indicating that Fas plays a role in lymphoid cell development. Lymphoid and hematopoietic cells share common pluripotent stem cells: and Fas is expressed on myeloid cell lines such as HL-60 and U-9374 and terminally differentiated myeloid cells, ie, neutrophils and monocytes.' These facts suggest that Fas may be actively involved in hematopoietic as well as lymphoid cell development.
We investigated the expression of Fas on CD34+ hematopoietic progenitor cells obtained from bone marrow (BM) in the presence or absence of interferon-y (IFN-7) and/or tumor necrosis factor-cu (TNF-a).
H MATERIALS AND METHODS
Preparation of BM CD34' cells. CD34' cells were isolated from BM of normal volunteers, as previously described, with minor mcdifications." Informed consent was obtained from all volunteers. BM was aspirated from the posterior iliac crest into syringes containing preservative-free heparin. Light-density BM mononuclear cells (BMMNC) were isolated by Ficoll-Hypaque density-gradient centrifugation (Lymphocyte separation medium; Organon Teknika CO, Durham, NC). After cells were washed twice with Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) supplemented with 10% fetal calf serum (FCS; Flow Laboratories Inc, McLean, VA), cells (2 X 106/mL) were suspended in IMDM with 10% FCS and incubated for 2 hours in a Petri dish to deplete adherent cells. The nonadherent BMMNC suspended in IMDM with 10% FCS were incubated with CD34-conjugated immunomagnetic beads (Dynabeads M-450 CD34; Dynal A S , Oslo, Norway) for 1 hour at 4°C with gentle rotation. CD34+ cells were then collected with a magnet (MPC-1; Dynal AS.). CD34-conjugated immunomagnetic beads were released by incubation with a goat-antimouse-Fab polyclonal Ab (DETACHaBEADS; Dynal A.S.) at room temperature for 90 minutes with gentle rotation. Contaminated T cells and B cells were then removed by using CD2-conjugated and CD19-conjugated immunomagnetic beads (Dynabeads M-450 PanT and PanB: Dynal A.S.). More than 95% of these isolated cells expressed CD34 when analyzed by flow cytometry (data not shown).
Monoclonal antibodies (MoAbs). Phycoerythrin (PE)-conjugated HPCA-2 (anti-CD34; IgGl), PE-conjugated GICL (control; IgGl), and fluorescein isothiocyanate (FITC)-conjugated GICL (control: IgGI) were purchased from Becton Dickinson (Mountain View, CA). Anti-Fas MoAb (CH-11; IgM K), which induces apoptosis by binding to Fas, and FITC-conjugated anti-Fas MoAb (UB2; IgGl), which does not induce apoptosis, were purchased from Medical & Biological Laboratories CO (Nagoya, Japan). Isotypematched control IgM (TEPC 183) was purchased from Sigma Chemical (St Louis, MO). Antihuman IFN-y-neutralizing MoAb was purchased from Genzyme (Cambridge, MA). Antihuman TNF-aneutralizing MoAb was kindly provided by Dainippon Pharmaceuti-Fas mRNA+ 384 bp cal CO (Osaka, Japan). Anti-p55 TNF-a receptor MoAb HTR-9 (IgGI) and anti-p75 TNF-a receptor MoAb UTR-I (IgGI) were kindly provided by Dr Manfred Brockhaus (F. Hoffman-LaRoche, Basel, Switzerland)." HTR-9 has an agonistic effect on p55 TNFa receptor, whereas UTR-I has an antagonistic effect on p75 TNFa receptor. Anti-p55 TNF-a receptor MoAb H398, which has an antagonistic effects on p55 TNF-a receptor, was purchased from Bender MedSystem (Vienna, Austria). Now cytometric analvsis. Quantitative fluorescent analysis was performed using a FACScan flow cytometer (Becton Dickinson). All incubations were performed at 4°C in phosphate-buffered saline (PBS) containing 0. I% sodium azide (binding buffer). Samples were washed with the binding buffer, suspended in 0. I mL of the binding buffer containing 1 mglmL of y-globulin (Sigma Chemical), and incubated for 15 minutes. The cells were washed with ice-cold binding buffer and incubated with 80 ng of PE-conjugated HPCA-2 and FITC-conjugated anti-Fas MoAb for 30 minutes. The cells were again washed twice with ice-cold binding buffer and then resuspended in ice-cold binding buffer for flow cytometric analysis. The background levels of fluorescence were established by incubating cells with isotype-matched PE-conjugated GICL and FITC-conjugated GICL.
Cytokines. Recombinant human (rh) stem cell factor (SCF), interleukin-3 (IL-3). IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF, and erythropoietin (Epo) were kindly provided by Kirin Brewery CO (Tokyo, Japan). rhlFN-y was kindly provided by Shionogi Pharmaceutical CO (Tokyo, Japan). rhTNF-a was kindly provided by Dainippon Pharmaceutical Co.
Liquid culture. CD34' cells (1 X 104/well) were cultured in 1 mL of serum-free medium (Ajinomoto serum free medium 1 0 4 ; Ajinomoto, Yokohama, Japan) supplemented with 1.0% deionized bovine serum albumin (BSA; Cohn fraction V; Sigma Chemical), 200 pglmL iron-saturated human transferrin (Sigma Chemical), 7.8 pglmL unfiltered cholesterol (Wako Pure Chemical Industries, Osaka, Japan), and 5 X IO-' moVL 2-mercaptoethanol (2-ME). Cultures were maintained at 37°C in a humidified atmosphere with 5% CO?, for 48 hours. The cells were incubated with different combinations of cytokines. Cytokine concentrations used in this study were 1 0 0 n g h L for SCF, 1 0 0 UlmL for IFN-y and 10 U1 mL for TNF-a. To determine whether the induced Fas can mediate apoptosis in response to anti-Fas MoAb (IgM), we added 1 pg/mL of anti-Fas MoAb or isotype-matched control IgM (TEPC 183) to cells at 36 hours of culture. We examined numbers of colony-forming cells (CFC) present after another 12 hours of incubation by culturing cells in a 0.1-mL v01 of the cell suspension. The viable cells were counted by Trypan blue dye exclusion method and DNA fragmentation was assessed. The cultured cells spun on a cytocentrifuge slide (Cytospin; Shandon Southern Instruments, Sewickley, PA) were examined morphologically after May-Griinwald-Giemsa staining. Quantitative fluorescent analysis was performed concurrently.
Clonogenic progenitor assays. Clonogenic progenitor assays were performed by the methylcellulose culture method, as previously described with minor modifications." Briefly, I X 10' freshly isolated CD34' cells and cultured CD34' cells were washed three times with IMDM and cultured in triplicate in I mL of IMDM supplemented with 30% FCS, 50 ng of SCF, 50 ng of IL-3, IO ng of IL-6, I O ng of GM-CSF, I O ng of G-CSF, 3 U of Epo, 5 X mol/L 2-ME, and 0.8% methylcellulose in 35-mm culture dishes (Lux5221, Naperville, IL) at 37°C in a humidified atmosphere with 5% CO2 and 5% O?. After 14 days of culture. erythroid bursts (BFU-E), granulocytelmacrophage colonies (CFU-GM), and mixed-cell colonies (CFU-Mix) were counted under an inverted microscope. The mean numbers of BFU-E, CFU-GM, and CFU-Mix colonies were 51.0 t 14.8, 43.0 t 13.0. and 5.4 ? 4.7 in 1 X 10' CD34' cells freshly isolated from three volunteers, respectively.
Reverse transcriptase-polymerase chain reaction (RT-PCR). RNA was prepared from I X IO4 freshly isolated CD34' cells and for I minute, were performed on a programmed-temperature system (PC-700; Astec, Fukuoka, Japan). PCR samples were electrophoresed on an ethidium bromide-stained 1.5% agarose gel. Primer sequences were as follows: 5'-ATGCTGGGCATCTGGACC-CTCCTA-3' and 5'-TCTGCACTTGGTATTCTGGGTCCG-3' for amplification of Fas mRNA' and 5'-GCACTCTTCCAGCCTTTC-CTG-3' and 5'-GGAGTACTTGCGCTCAGGAGGAGC-3' for amplification of &actin mRNA."
Detection of DNA frugrnenrarion. Pellets obtained from 1 X IO6 cells were mixed with 500 pL of 5 mmol/L Tris-HCI (pH 7.4). 5 mmol/L EDTA, and 0.5% Triton-X (Wako Pure Chemical Industries). Samples were incubated with 200 p g h L of RNase A (Boehringer Mannheim) for 1 hour at 37°C and then with 400 &mL of Proteinase K (Wako Pure Chemical Industries) for 2 hours at 60°C. Samples were extracted with phenol-chloroform and precipitated with ethanol. After air-drying, DNA was dissolved with 8 pL of 10 mmol/L Tris-HC1, pH 7.4, I mmol/L EDTA, 1% sodium dodecyl sulfate (SDS) and electrophoresed in an ethidium bromide-stained 1.5% agarose gel at 80 V for 3 hours.
Srurisricul analysis. Data were analyzed with the two-tailed Student's r-test. A P value <.05 was considered to indicate a statistically significant difference.
RESULTS

Fas expression on CD34+ cells. Both flow cytometric analysis and RT-PCR did not detect any expression of Fas
and Fas mRNA, respectively, in CD34' cells freshly isolated from BM (Figs 1 and 2 ). IFN-y and/or TNF-a induced the expression of both Fas mRNA and Fas itself on the surface of CD34' cells in a dose-dependent fashion after 48 hours of serum-free culture (Figs 1 through 3) . The addition of anti-IFN-y or anti-TNF-a neutralizing MoAbs to the culture blocked the expression of Fas induced by IFN-y or by TNF-a, respectively (data not shown). When both IFN-y and TNF-a were added to the culture, they showed a synergistic effect on the induction of Fas (Fig 2) . To clarify which p55 or p75 TNF-a receptor mediates the TNF-a-induced Fas expression on CD34' cells, we used specific anti-p55 and anti-p75 TNF-(U receptor MoAbs. With the addition of 10 pg/mL of HTR-9, CD34' cells were induced to express Fas. The induction of Fas expression on CD34' cells by TNF-a was blocked by the addition of 10 pg/mL of H398, whereas the addition of IO pg/mL of UTR-I did not affect the induction of Fas by TNF-(U (Fig 4) . These data clearly indicated that the TNF-a-induced Fas expression is medi- ated by p55 TNF-(U receptor. When CD34' cells were cultured in medium alone or with SCF, some slight expression of Fas was observed (Figs 1 and 2) . 
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tions, DNA fragmentation, and numbers of CFC present after another 12 hours of incubation. The addition of anti-Fas MoAb (IgM) significantly reduced the number of viable cells compared with that of control Ab ( P < .OS) (Fig S) . Figure   6 shows that apoptotic cells morphologically defined as based on cytoplasmic condensation and nuclear fragmentation were increased in proportion after the addition of antiFas MoAb (IgM). The addition of anti-Fas MoAb (IgM) to CD34' cells cultured with SCF, IFN-7, and TNF-a induced DNA fragmentation (Fig 7) . Furthermore, the addition of anti-Fas MoAb (IgM) significantly reduced the number of CFC including both CFU-GM and BFU-E compared with that of control Ab ( P < .OS) (Fig 8) . However, no significant difference in the number of viable cells (Fig S) or no significant difference in the number of CFC was observed (Fig 8) when anti-Fas MoAb (IgM) was added to CD34" cells cultured with SCF.
DISCUSSION
Constitutive hematopoiesis, including proliferation and differentiation of various types of progenitor cells in BM, is elegantly regulated to maintain a homeostatic condition for well-balanced production of mature blood cells. Thus, cell death, which is the terminal event of constitutive hematopoiesis, is also probably regulated. Most hematopoietic growth factors, including SCF, 1L-3, GM-CSF, G-CSF, and Epo, have been found to play an important role in prevention of apoptosis of progenitor Senescent monocytes, neutrophils, and eosinophils are known to undergo apoptosi~.'~''~ Thus, hematopoiesis appears to be regulated by both the apoptosis of senescent blood cells and the balance between proliferation and apoptosis of progenitor cells. ' In the Dresent studv. IFN-v and/or TNF-a. well known as negative hematopoietic regulators, induced the strong expression of functional Fas on hematopoietic progenitor cells. It has been established that TNF-a via p55 TNF-a receptor can mediate the downregulation of G-CSF receptor and ckit and the upregulation of IL-3 and GM-CSF receptor^.^".'^ We showed that TNF-a via p55 TNF-a receptor mediates the upregulation of Fas. Fas belongs to NGFR/TNFR superfamily, and has homology with p55 and p75 TNF-a receptors in their extracellular regions, and homology with p55 TNF-NAGAFUJI ET AL a receptor in their intracellular signaling domain which is considered to mediate the death signal.' It is interesting that p55 TNF-a receptor, which is considered to be mediate TNFa-induced cytotoxicity," also mediates the TNF-a-induced Fas expression, which is the receptor for the death signal. For personal use only. on November 16, 2017. by guest www.bloodjournal.org From
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